share_log

12 Health Care Stocks Moving In Thursday's After-Market Session

Benzinga ·  Mar 7 16:31

Gainers

  • Ainos (NASDAQ:AIMD) shares moved upwards by 100.0% to $2.24 during Thursday's after-market session. The market value of their outstanding shares is at $10.4 million.
  • Talphera (NASDAQ:TLPH) stock moved upwards by 9.25% to $1.24. The market value of their outstanding shares is at $21.0 million. The company's, Q4 earnings came out yesterday.
  • Unicycive Therapeutics (NASDAQ:UNCY) stock rose 8.66% to $1.63. The company's market cap stands at $56.6 million.
  • Bio-Path Hldgs (NASDAQ:BPTH) shares increased by 7.8% to $6.49. The market value of their outstanding shares is at $4.0 million.
  • Akili (NASDAQ:AKLI) stock increased by 7.59% to $0.34. The market value of their outstanding shares is at $26.6 million.
  • Kiora Pharmaceuticals (NASDAQ:KPRX) shares rose 4.99% to $0.7. The company's market cap stands at $16.4 million.

Losers

  • Biofrontera (NASDAQ:BFRI) shares declined by 15.1% to $1.01 during Thursday's after-market session. The company's market cap stands at $5.1 million.
  • Creative Medical Tech (NASDAQ:CELZ) shares decreased by 11.59% to $5.57. The market value of their outstanding shares is at $7.6 million.
  • Nexalin Technology (NASDAQ:NXL) stock declined by 11.47% to $0.48. The market value of their outstanding shares is at $3.5 million.
  • Macrogenics (NASDAQ:MGNX) shares declined by 10.49% to $18.36. The company's market cap stands at $1.1 billion. The company's, Q4 earnings came out today.
  • Immuron (NASDAQ:IMRN) shares decreased by 8.14% to $4.18. The company's market cap stands at $23.8 million.
  • NKGen Biotech (NASDAQ:NKGN) shares fell 7.25% to $1.79. The market value of their outstanding shares is at $39.1 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment